Plain-English translation of NCT07274657 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing two advanced imaging techniques — called SMI (Superb Microvascular Imaging) and 2D-SWE-EUS (a specialized ultrasound elastography method) — to help doctors better identify and diagnose pancreatic cancer and other pancreatic tumors. These new imaging methods work during a specialized ultrasound procedure that doctors already use to look at the pancreas. The goal is to improve how accurately doctors can tell the difference between dangerous and less dangerous pancreatic tumors.
Currently, standard imaging methods can correctly identify pancreatic cancer only about 50–70% of the time, which means some cancers are missed or misdiagnosed. Doctors need better tools to reliably distinguish pancreatic cancer from other pancreatic tumors so they can recommend the right treatment quickly.
You likely qualify if…
You likely don't qualify if…
You would undergo a specialized ultrasound procedure called endoscopic ultrasound (EUS), where a thin scope is gently passed down your throat to obtain detailed images of your pancreas using the two new imaging techniques being studied. The procedure itself is similar to ones doctors already perform routinely. You may also have a small tissue sample taken during the procedure to confirm the diagnosis, which is standard medical practice. The entire process typically takes less than an hour, and you would be given sedation to keep you comfortable.
AI-generated summary from trial data · Aug 24, 2026 · Not medical advice
France